Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications
Plouin, P.F.
Therapie 39(4): 379-390
1984
ISSN/ISBN: 0040-5957 PMID: 6148791 Document Number: 233434
Document emailed within 1 workday
Related Documents
Botting, J.H.; Gibson, A. 1979: Beta-blocker withdrawal syndrome Lancet 1(8121): 875-876Halawa, B. 1981: Complications associated with sudden withdrawal of various drugs used in the treatment of cardiovascular diseases Wiadomosci Lekarskie 34(6): 491-495
Giliarevskiĭ, S.R. 2006: Practical approaches to selection of beta-adrenoblocker for the treatment of cardiovascular diseases: novel evidence based data Kardiologiia 46(11): 79-85
Furberg, C.D.; Byington, R.P. 1983: What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience Circulation 67(6 Part 2): I98-101
Carre, A. 1975: Alpha- and beta-blocker combination in cardiovascular pathology Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 20(6): 536-538
Yoshida, T.; Takano, M.; Tamura, A.; Kubota, H.; Suzuki, N. 1970: Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46 Masui. Japanese Journal of Anesthesiology 19(5): 515-522
Klaus, F.; Dorsaz, O.; Kaiser, S. 2018: Negative symptoms in schizophrenia - overview and practical implications Revue Medicale Suisse 14(619): 1660-1664
Löllgen, H.; Schmidt, A.; Upmeyer, H.J. 1986: Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension Medizinische Klinik 81(23): 745-750
Bots, M.L.; van der Bom, J.G.; de Bruyne, M.C.; Grobbee, D.E. 2002: Cardiovascular risk factors. II. Signs of vascular damage: practical implications Nederlands Tijdschrift Voor Geneeskunde 146(25): 1174-1178
Guédon, J.; Lucsko, M.; Cuche, J.L.; Chaignon, M. 1979: Renovascular hypertension and beta blockers. Theoretical and practical implications Archives des Maladies du Coeur et des Vaisseaux 72(Special Issue): 9-15
Niemelä, S. 2011: Treatment of alcohol withdrawal symptoms Duodecim; Laaketieteellinen Aikakauskirja 127(13): 1373-1377
Fagerström, K.O. 1999: Tobacco withdrawal symptoms and treatment Monaldi Archives for Chest Disease 54(6): 485-488
Gauché, W.G. 1984: Propranolol for the treatment of diazepam withdrawal symptoms South African Medical Journal 66(23): 870
Böhm, M. 1996: Treatment with a beta blocker and digitalis Der Anaesthesist 45(9): 868
Von Albert, H.H. 1983: Therapy in neurology. 12. Predelirium withdrawal symptoms and their treatment Fortschritte der Medizin 101(1-2): 17-21
Chouinard, G.; Bradwejn, J.; Annable, L.; Jones, B.D.; Ross-Chouinard, A. 1984: Withdrawal symptoms after long-term treatment with low-potency neuroleptics Journal of Clinical Psychiatry 45(12): 500-502
Bianchini, C.; Terzoli, L.; Leonetti, G.; Banfi, E.; Castelli, D.; Zanchetti, A. 1982: Hypotensive and renin-stimulating action of captopril at first and during treatment with a beta-blocker Cardiologia 27(4): 381-385
Staben, P.; Müller, U. 1983: Treatment of hypertension with the beta blocker Corindolan. Results of a field study Die Medizinische Welt 34(33-34): 909-913
Vormittag, E. 1974: The influence of beta receptor blockade on the incidence of postoperative cardiovascular complications Wiener Klinische Wochenschrift 86(16): 474-476
Halpern, J.; Catane, R.; Baerwald, H. 1984: A call for caution in the use of aminoglutethimide: negative interactions with dexamethasone and beta blocker treatment Journal of Medicine 15(1): 59-63